TY - JOUR
T1 - Risk Stratification and Interventional Cardiology
T2 - Robert L. Frye Lecture
AU - Holmes, David R.
PY - 2003/12
Y1 - 2003/12
N2 - Risk stratification and risk-benefit ratios are extremely important in guiding patient-physician interactions as well as patient and family counseling. Risks associated with percutaneous transluminal coronary angioplasty are (1) compromise of the vessel lumen or vessel integrity, (2) unsuccessful procedure, and (3) restenosis. Predicting mortality risk depends on the specific patient population to be treated and on the specific mortality model used. The most common models are those from New York State, the American College of Cardiology, the Northern New England Cooperative Group, the University of Michigan, and The Cleveland Clinic Foundation. As more data and sophisticated analyses become available, risk stratification will become more accurate as long as the approach used is straightforward, makes intuitive sense, and is easy and efficient to apply.
AB - Risk stratification and risk-benefit ratios are extremely important in guiding patient-physician interactions as well as patient and family counseling. Risks associated with percutaneous transluminal coronary angioplasty are (1) compromise of the vessel lumen or vessel integrity, (2) unsuccessful procedure, and (3) restenosis. Predicting mortality risk depends on the specific patient population to be treated and on the specific mortality model used. The most common models are those from New York State, the American College of Cardiology, the Northern New England Cooperative Group, the University of Michigan, and The Cleveland Clinic Foundation. As more data and sophisticated analyses become available, risk stratification will become more accurate as long as the approach used is straightforward, makes intuitive sense, and is easy and efficient to apply.
UR - http://www.scopus.com/inward/record.url?scp=0345293095&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=0345293095&partnerID=8YFLogxK
U2 - 10.4065/78.12.1507
DO - 10.4065/78.12.1507
M3 - Article
C2 - 14661680
AN - SCOPUS:0345293095
VL - 78
SP - 1507
EP - 1518
JO - Mayo Clinic Proceedings
JF - Mayo Clinic Proceedings
SN - 0025-6196
IS - 12
ER -